XML 42 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Description of Business and Bankruptcy Proceedings (Details Textual)
8 Months Ended 12 Months Ended
Jun. 20, 2016
USD ($)
shares
May 05, 2016
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2014
shares
May 04, 2016
$ / shares
Dec. 31, 2015
$ / shares
Common Stock, Par or Stated Value Per Share | $ / shares     $ 0.0001 $ 0.0001   $ 0.0001 $ 0.0001
Payment for Offering Cost | $   $ 100,000          
Warrant, Expiration Date   May 05, 2021          
Class of Warrant or Right, Date from which Warrants or Rights Exercisable   Nov. 05, 2016          
Preferred Stock, Shares Authorized     1,000,000 1,000,000      
Preferred Stock, Par or Stated Value Per Share | $ / shares     $ 0.0001 $ 0.0001      
Preferred Stock, Liquidation Preference, Value | $     $ 29,038,000 $ 29,038,000      
Arthrex [Member]              
Reduction in Allowed Claim | $   $ 15,000,000          
Series A Preferred Stock [Member]              
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.0001          
Stock Issued During Period, Shares, New Issues   29,038          
Preferred Stock, Shares Authorized   29,038          
Preferred Stock, Par or Stated Value Per Share | $ / shares   $ 0.0001          
Preferred Stock, Liquidation Preference, Value | $   $ 29,038,000          
Number of Board Members Nominated and Elected by Shareholders   1          
Preferred Stock, Voting Rights, Number of Votes Per Share   5          
Preferred Stock, Voting Rights, Percentage of Voting Rights of Capital Stock   1.00%          
Common Stock [Member]              
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.0001          
Stock Issued During Period, Shares, New Issues   7,500,000 2,264,612        
Proceeds from Issuance of Common Stock | $   $ 7,300,000          
Proceeds from Issuance of Common Stock, Net of Issuance Costs | $   $ 7,052,500          
Stock Issued During Period, Shares, Other   200,000     2,709,677    
Payment for Offering Cost | $   $ 100,000          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   6,180,000          
Warrant, Expiration Date   May 05, 2021          
Class of Warrant or Right, Date from which Warrants or Rights Exercisable   Nov. 05, 2016          
Backstop Commitment Date   Jun. 30, 2017          
Commitment Fees for Debt | $   $ 250,000          
Stock Issued During Period, Shares, Issued for Services     162,500        
Common Stock [Member] | Backstop Commitment [Member]              
Number of Shares Commited to Purchase   12,800,000          
Value of Shares Commited to Purchase | $   $ 3,000,000          
Common Stock [Member] | Minimum [Member]              
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares   $ 0.50          
Common Stock [Member] | Maximum [Member]              
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares   $ 1          
Exchange Shares [Member]              
Stock Issued During Period, Shares, New Issues   2,264,612          
Number of Shares Commited to Issue   3,000,000          
Shares of Old Common Stock to New Common Stock, Conversion Ratio   41.8934          
Administrative Claim Shares [Member]              
Stock Issued During Period, Shares, New Issues 162,500            
Stock Issued During Period, Shares, Issued for Services 100,000            
Debt Conversion, Converted Instrument, Shares Issued 62,500            
Debt Conversion, Original Debt, Amount | $ $ 62,500            
Platelet Rich Plasma (PRP) [Member]              
Number of Products Produced       2